SCHEMBL5484644

SCHEMBL5484644

CS(=O)(=O)Nc1cccc(Oc2ccc3c(c2)S(O)(O)NCN3CCF)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 7/20 0.40
PGR P06401 1/20 0.36
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
POLB P06746 1/20 0.35
PIP4K2A P48426 1/20 0.35
PIP4K2B P78356 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNA1B Q00975 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
DRD2 P14416 2/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
DHX9 Q08211 1/20 0.34
ABL1 P00519 1/20 0.34
MAP2K1 Q02750 1/20 0.34
BTK Q06187 1/20 0.34
ADRA1D P25100 1/20 0.34
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5482709 0.92 LTA4H (0.41) GRIA2PGRGRIN1GRIN2BSLC6A4
SCHEMBL5484649 0.90 GRIA2 (0.51) GRIA2PGRABL1
SCHEMBL5621041 0.90 GRIA2 (0.40) GRIA2PGRF2F10POLB
SCHEMBL5477040 0.85 GRIA2 (0.39) GRIA2POLB
SCHEMBL5479955 0.82 GRIA2 (0.39) GRIA2POLBSLC6A4
SCHEMBL5483529 0.81 GRIA2 (0.41) GRIA2F2F10DRD2
SCHEMBL5482710 0.81 GRIA2 (0.54) GRIA2PGR
SCHEMBL5620019 0.81 GRIA2 (0.39) GRIA2PGRCACNA1HCACNA1BSLC6A4
SCHEMBL5621042 0.79 GRIA2 (0.53) GRIA2PGRDRD2DRD4DRD3
SCHEMBL5486900 0.79 GRIA2 (0.40) GRIA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655030-B1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB (FR) 2007-12-19 EP disclosed
US-20070270415-A1 Benzothiadiazine compounds LESLABORATOIRES SERVIER (FR) 2007-11-22 US disclosed
US-7268130-B2 Benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-09-11 US disclosed
EP-1655030-A1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same Les Laboratoires Servier (FR) 2006-05-10 EP disclosed
US-20060094712-A1 New benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270415-A1 Benzothiadiazine compounds SLC1A1, SLC1A2, SULT2A1 GRIA2 47/4885PGR 2853/4885F2 2588/4885
US-20060094712-A1 New benzothiadiazine compounds SLC1A1, SLC1A2, GABRA5 GRIA2 36/4885PGR 3335/4885F2 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.